Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013:2013:563481.
doi: 10.1155/2013/563481. Epub 2012 Dec 30.

Neurodegenerative Diseases: Multifactorial Conformational Diseases and Their Therapeutic Interventions

Affiliations
Review

Neurodegenerative Diseases: Multifactorial Conformational Diseases and Their Therapeutic Interventions

Saba Sheikh et al. J Neurodegener Dis. 2013.

Abstract

Neurodegenerative diseases are multifactorial debilitating disorders of the nervous system that affect approximately 30 millionindividuals worldwide. Neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, and amyotrophic lateral sclerosis diseases are the consequence of misfolding and dysfunctional trafficking of proteins. Beside that, mitochondrial dysfunction, oxidative stress, and/or environmental factors strongly associated with age have also been implicated in causing neurodegeneration. After years of intensive research, considerable evidence has accumulated that demonstrates an important role of these factors in the etiology of common neurodegenerative diseases. Despite the extensive efforts that have attempted to define the molecular mechanisms underlying neurodegeneration, many aspects of these pathologies remain elusive. However, in order to explore the therapeutic interventions directed towards treatment of neurodegenerative diseases, neuroscientists are now fully exploiting the data obtained from studies of these basic mechanisms that have gone awry. The novelty of these mechanisms represents a challenge to the identification of viable drug targets and biomarkers for early diagnosis of the diseases. In this paper, we are reviewing various aspects associated with the disease and the recent trends that may have an application for the treatment of the neurodegenerative disorders.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Different factors associated with neurodegenerative disease.

Similar articles

Cited by

References

    1. Dobson C. M. Protein folding and misfolding. Nature. 2003;426(6968):884–890. doi: 10.1038/nature02261. - DOI - PubMed
    1. Hartl F. U., Hayer-Hartl M. Converging concepts of protein folding in vitro and in vivo. Nature Structural and Molecular Biology. 2009;16(6):574–581. doi: 10.1038/nsmb.1591. - DOI - PubMed
    1. Balch W. E., Morimoto R. I., Dillin A., Kelly J. W. Adapting proteostasis for disease intervention. Science. 2008;319(5865):916–919. doi: 10.1126/science.1141448. - DOI - PubMed
    1. Morimoto R. I. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes and Development. 2008;22(11):1427–1438. doi: 10.1101/gad.1657108. - DOI - PMC - PubMed
    1. Pegoraro G., Voss T. C., Martin S. E., Tuzmen P., Guha R., Misteli T. Identification of mammalian protein quality control factors by high-throughput cellular imaging. PLoS ONE. 2012;7(2) doi: 10.1371/journal.pone.0031684.e31684 - DOI - PMC - PubMed